Autoimmune liver disease-associated serologic profiling in Chinese patients with acute hepatitis E virus infection
Open Access
- 28 January 2021
- journal article
- research article
- Published by Springer Nature in Immunologic Research
- Vol. 69 (1) , 81-89
Abstract
The association between hepatitis E virus (HEV) and autoimmune liver diseases has been well-researched; however, the focus has been on autoimmune hepatitis (AIH) and not primary biliary cholangitis (PBC). Therefore, we aimed to investigate the prevalence and evolution of AIH- and PBC-related autoantibodies in Chinese patients with HEV infection. In this retrospective study, 164 patients with acute HEV were included, specifically those whose liver autoantibody results were available and who had no pre-existing liver disease at the time of HEV diagnosis. Positive liver autoimmune serology was present in 69 (42.1%) patients and 21 (12.8%) had at least two autoantibodies at diagnosis. Greater age and alkaline phosphatase levels were independent risk factors for autoantibody positivity. Follow-up serologic tests, which were available for 27 of the 69 autoantibody-positive patients, showed that although antinuclear antibodies disappeared in 11/20 (55.0%) and antimitochondrial antibodies disappeared in 4/5 (80%) patients, 16 still remained positive for autoantibodies and two of them even developed new PBC-related antibodies, as described below. One patient developed a rim-like ANA pattern, accompanied by an enhancement of anti-gp210 positivity; and the other was diagnosed as PBC, based on chronic elevation of cholestatic enzymes and presentation with de novo AMA-M2, 18 months after HEV clearance. In conclusion, AIH- and PBC-related autoantibodies are frequently present during acute HEV infection, indicating that HEV should be excluded before diagnosing AIH and/or PBC. Importantly, some cases maintained or developed autoantibodies after viral clearance, and one patient subsequently developed PBC, highlighting that these individuals warrant long-term follow-up.Keywords
Funding Information
- the Shanghai Three-Year Plan of the Key Subjects Construction in Public Health-Infectious Diseases and Pathogenic Microorganism (15GWZK0102)
- the Shanghai Three-Year Plan of the Clinical Skills and Innovations (16CR1002A)
- the Shanghai Municipal Key Clinical Specialty (shslczdzk01103)
- Key Projects in the National Science and Technology Pillar Program during the Thirteen Five-year Plan Period (2017ZX10203202)
This publication has 36 references indexed in Scilit:
- EASL Clinical Practice Guidelines: Autoimmune hepatitisJournal of Hepatology, 2015
- Increased HEV Seroprevalence in Patients with Autoimmune HepatitisPLOS ONE, 2014
- Autoantibody profile in individuals with chronic hepatitis CRevista da Sociedade Brasileira de Medicina Tropical, 2013
- Immunopathogenesis of Hepatitis E Virus InfectionSeminars in Liver Disease, 2013
- Case of acute hepatitis E with concomitant signs of autoimmunityWorld Journal of Hepatology, 2013
- Early primary biliary cirrhosis: Biochemical response to treatment and prediction of long-term outcomeJournal of Hepatology, 2011
- Antimitochondrial antibodies in acute liver failure: Implications for primary biliary cirrhosisHepatology, 2007
- Prevalence of antinuclear autoantibodies in the serum of normal blood dornorsRevista Do Hospital Das Clinicas, 2003
- Anti-multiple nuclear dots (anti-MND) and anti-SP100 antibodies in hepatic and rheumatological disordersClinical and Experimental Immunology, 2002
- Hepatitis E in Patients With Chronic Autoimmune Liver DiseaseJAMA, 1995